La Marine vise toujours l’IOC de l’AARGM-ER en septembre 2026

A key missile still moving toward service entry

The US Navy says it remains on track to field the AGM-88G Advanced Anti-Radiation Guided Missile-Extended Range, or AARGM-ER, in September 2026, despite a planned pause in procurement during fiscal 2027. That combination of near-term operational ambition and short-term buying restraint has made the program one of the more closely watched munitions stories in naval aviation.

AARGM-ER is designed to give carrier air wings a stronger ability to attack hostile integrated air defense systems. That mission has become more important as potential adversaries field denser, longer-range, and more networked air defense architectures. In any conflict where US aircraft must operate in heavily contested airspace, suppressing or destroying enemy radars and associated defenses is a prerequisite for broader freedom of action.

The missile has been in development since the late 2010s, with Northrop Grumman as prime contractor through its acquisition of Orbital ATK. The Navy has already ordered dozens of rounds. That is why the absence of procurement funding in the service’s proposed fiscal 2027 budget drew immediate attention.

Why the “strategic pause” raised alarms

On its face, a pause in missile purchases can mean several different things. It can reflect budget pressure, industrial bottlenecks, unresolved technical issues, a software maturity problem, or a deliberate decision to stop buying until testing is complete. In AARGM-ER’s case, the Navy says the pause is tied to the last of those factors.

A Navy spokesperson told The War Zone that US procurement will resume after the system completes the necessary testing and software updates. The immediate priority, according to the service, is meeting the milestones required for Initial Operational Capability in September 2026. After that validation work, the Navy says it intends to ramp production back up and clear a backlog of more than 150 missiles, with US procurement officially restarting in fiscal 2028.

That explanation provides more clarity than the budget alone did, but it does not erase concern. Programs that encounter testing and software problems often discover that schedule recovery is harder than planned, particularly when the weapon in question is intended for a demanding suppression-of-enemy-air-defenses role.

A program at an inflection point

The AARGM-ER story is now less about whether the missile is needed than whether the Navy can transition it cleanly from development into credible service use. The service’s insistence that IOC is still coming in 2026 suggests institutional confidence. The procurement pause suggests that confidence is conditional on hard technical milestones being met first.

That is a defensible position if the remaining issues are contained and fixable. It is harder to sustain if new problems emerge. For now, the Navy is trying to hold both ideas at once: the weapon is strategically important enough to field this year, and not mature enough to justify new domestic buys next year.

How that balance resolves will determine whether AARGM-ER becomes a case study in disciplined acquisition correction or another reminder that the final stretch of weapons development is often the most revealing. By September, the Navy expects to have its answer.

This article is based on reporting by twz.com. Read the original article.

Navy Still Aims to Field AARGM-ER in 2026 Despite Procurement Pause

A key missile still moving toward service entry

Why the “strategic pause” raised alarms

Keep Reading

Le MQ-25 Stingray de la Marine franchit un cap clé avec le premier vol d’un appareil représentatif de la production

Why AARGM-ER matters strategically

Foreign sales keep the line active

The risks ahead

A program at an inflection point

Comments (0)